{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:40:45Z","timestamp":1792370445750,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00772-6","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:26:03Z","timestamp":1782581163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene prioritization across ancestries uncovers distinct molecular pathophysiology and therapeutic landscape in polycystic ovary syndrome"],"prefix":"10.1038","volume":"12","author":[{"given":"Sindhuja","family":"Rajavelu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debojyoti","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin, E. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Prim. 10, 27 (2024).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"772_CR2","first-page":"e27689","volume":"14","author":"S Akre","year":"2022","unstructured":"Akre, S., Sharma, K., Chakole, S. & Wanjari, M. B. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus 14, e27689 (2022).","journal-title":"Cureus"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink, J. M., Sadrzadeh, S., Lambalk, C. B. & Boomsma, D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100\u20132104 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","volume":"95","author":"RS Legro","year":"1998","unstructured":"Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J. & Dunaif, A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA 95, 14956 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"772_CR5","doi-asserted-by":"publisher","unstructured":"Day, F. et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. https:\/\/doi.org\/10.1371\/journal.pgen.1007813 (2018).","DOI":"10.1371\/journal.pgen.1007813"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook, D. et al. Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework. Nat. Rev. Drug Discov. 13, 419\u2013431 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","volume":"14","author":"MJ Waring","year":"2015","unstructured":"Waring, M. J. et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14, 475\u2013486 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","volume":"1","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann, E. et al. Genome-wide association studies. Nat. Rev. Methods Prim. 1, 59 (2021).","journal-title":"Nat. Rev. Methods Prim."},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/molehr\/gax046","volume":"23","author":"SY Ji","year":"2017","unstructured":"Ji, S. Y. et al. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse. Mol. Hum. Reprod. 23, 698\u2013707 (2017).","journal-title":"Mol. Hum. Reprod."},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41431-021-00835-8","volume":"29","author":"JC Censin","year":"2021","unstructured":"Censin, J. C., Bovijn, J., Holmes, M. V. & Lindgren, C. M. Colocalization analysis of polycystic ovary syndrome to identify potential disease-mediating genes and proteins. Eur. J. Hum. Genet. 29, 1446 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"772_CR12","doi-asserted-by":"crossref","unstructured":"Zhang, J. H. et al. Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome. Front. Endocrinol. 13, 971564 (2022).","DOI":"10.3389\/fendo.2022.971564"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.21608\/ejhm.2018.9088","volume":"72","author":"MA Laban","year":"2018","unstructured":"Laban, M. A., Shemais, T. A., Elhelw, E. M. & El-Hassanin, A. R. Role of insulin like growth factor in polycystic ovary syndrome. Egypt J. Hosp. Med. 72, 4005 (2018).","journal-title":"Egypt J. Hosp. Med."},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11010-023-04736-w","volume":"479","author":"W Tan","year":"2024","unstructured":"Tan, W. et al. Insights on the NF-\u03baB system in polycystic ovary syndrome, attractive therapeutic targets. Mol. Cell. Biochem. 479, 467\u2013486 (2024).","journal-title":"Mol. Cell. Biochem."},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci. 22, 3789 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","volume":"89","author":"AA Bremer","year":"2008","unstructured":"Bremer, A. A. & Miller, W. L. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil. Steril. 89, 1039\u20131048 (2008).","journal-title":"Fertil. Steril."},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/endrev\/bnac013","volume":"43","author":"KL Clark","year":"2022","unstructured":"Clark, K. L. et al. Hippo signaling in the ovary: emerging roles in development, fertility, and disease. Endocr. Rev. 43, 1074\u20131096 (2022).","journal-title":"Endocr. Rev."},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/humrep\/des325","volume":"27","author":"D Haouzi","year":"2012","unstructured":"Haouzi, D. et al. Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome. Hum. Reprod. 27, 3523\u20133530 (2012).","journal-title":"Hum. Reprod."},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"118416","DOI":"10.1016\/j.biopha.2025.118416","volume":"191","author":"H Ziemak","year":"2025","unstructured":"Ziemak, H. et al. Angiogenesis in the ovary\u2013proangiogenic factors and their clinical applications. Biomed. Pharmacother. 191, 118416 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"1169232","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J., Yin, T. & Liu, S. Dysregulation of immune response in PCOS organ system. Front. Immunol. 14, 1169232 (2023).","journal-title":"Front. Immunol."},{"key":"772_CR21","first-page":"1","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target. Ther. 9, 1\u201337 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.4049\/jimmunol.1700352","volume":"198","author":"Q Zhu","year":"2017","unstructured":"Zhu, Q. & Kanneganti, T.-D. Distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1\u03b2. J. Immunol. 198, 4210 (2017).","journal-title":"J. Immunol."},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/s41431-020-0631-y","volume":"28","author":"FP Fernandes","year":"2020","unstructured":"Fernandes, F. P., Leal, V. N. C., Souza de Lima, D., Reis, E. C. & Pontillo, A. Inflammasome genetics and complex diseases: a comprehensive review. Eur. J. Hum. Genet. 28, 1307\u20131321 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu, Y. & Qiao, J. Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J. Healthc. Eng. 2022, 9240569 (2022).","journal-title":"J. Healthc. Eng."},{"key":"772_CR25","doi-asserted-by":"crossref","unstructured":"Brown, J. & Farquhar, C. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst. Rev. 12, (2016).","DOI":"10.1002\/14651858.CD002249.pub5"},{"key":"772_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108834","volume":"38","author":"B Austreg\u00e9silo de Athayde De Hollanda","year":"2024","unstructured":"Austreg\u00e9silo de Athayde De Hollanda Morais, B. et al. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials. J. Diab. Complications 38, 108834 (2024).","journal-title":"J. Diab. Complications"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly, N. S. et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum. Reprod. Update 24, 455\u2013467 (2018).","journal-title":"Hum. Reprod. Update"},{"key":"772_CR28","doi-asserted-by":"publisher","first-page":"e0312115","DOI":"10.1371\/journal.pone.0312115","volume":"19","author":"H Xue","year":"2024","unstructured":"Xue, H. et al. The mechanism of NF-\u03baB-TERT feedback regulation of granulosa cell apoptosis in PCOS rats. PLoS One 19, e0312115 (2024).","journal-title":"PLoS One"},{"key":"772_CR29","doi-asserted-by":"publisher","first-page":"e13093","DOI":"10.1111\/jne.13093","volume":"34","author":"CR McCartney","year":"2022","unstructured":"McCartney, C. R., Campbell, R. E., Marshall, J. C. & Moenter, S. M. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome. J. Neuroendocrinol. 34, e13093 (2022).","journal-title":"J. Neuroendocrinol."},{"key":"772_CR30","doi-asserted-by":"crossref","unstructured":"Liao, B., Qiao, J. & Pang, Y. Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front. Endocrinol. 12, 667422 (2021).","DOI":"10.3389\/fendo.2021.667422"},{"key":"772_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12020-024-04137-z","volume":"88","author":"KA Padder","year":"2025","unstructured":"Padder, K. A., Yousuf, M. A., Jahan, N., Yousuf, S. D. & Ganie, M. A. Interplay between elevated RAB5B gene expression and insulin resistance among women with PCOS-insights from a case-control study. Endocrine 88, 323\u2013329 (2025).","journal-title":"Endocrine"},{"key":"772_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.147062","volume":"852","author":"R Alan Harris","year":"2023","unstructured":"Alan Harris, R. et al. Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome. Gene 852, 147062 (2023).","journal-title":"Gene"},{"key":"772_CR33","doi-asserted-by":"crossref","unstructured":"Escobar-Morreale, H. F., Luque-Ram\u00edrez, M. & Gonz\u00e1lez, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil. Steril. 95, (2011).","DOI":"10.1016\/j.fertnstert.2010.11.036"},{"key":"772_CR34","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/ijms22052734","volume":"22","author":"S Aboeldalyl","year":"2021","unstructured":"Aboeldalyl, S. et al. The role of chronic inflammation in polycystic ovarian syndrome\u2014a systematic review and meta-analysis. Int. J. Mol. Sci. 22, 2734 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"772_CR35","doi-asserted-by":"crossref","unstructured":"Peng, Y. et al. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front. Endocrinol. 13, 845165 (2022).","DOI":"10.3389\/fendo.2022.845165"},{"key":"772_CR36","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/humrep\/des018","volume":"27","author":"M Guo","year":"2012","unstructured":"Guo, M. et al. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo\/amenorrhoea. Hum. Reprod. 27, 1481\u20131488 (2012).","journal-title":"Hum. Reprod."},{"key":"772_CR37","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1210\/jc.2005-2430","volume":"91","author":"JC Lo","year":"2006","unstructured":"Lo, J. C. et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 1357\u20131363 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"772_CR38","first-page":"305","volume":"1","author":"N Chahal","year":"2020","unstructured":"Chahal, N. et al. Comparison of metabolic syndrome elements in White and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study. FS Rep. 1, 305\u2013313 (2020).","journal-title":"FS Rep."},{"key":"772_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-024-01525-x","volume":"17","author":"D Tian","year":"2024","unstructured":"Tian, D., Chen, J. & Liu, L. Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study. J. Ovarian Res. 17, 1\u20137 (2024).","journal-title":"J. Ovarian Res."},{"key":"772_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm, T. V., Meier, D. T., Olefsky, J. M. & Donath, M. Y. Inflammation in obesity, diabetes, and related disorders. Immunity 55, 31\u201355 (2022).","journal-title":"Immunity"},{"key":"772_CR41","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1172\/JCI117495","volume":"94","author":"GS Hotamisligil","year":"1994","unstructured":"Hotamisligil, G. S., Budavari, A., Murray, D. & Spiegelman, B. M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Investig. 94, 1543\u20131549 (1994).","journal-title":"J. Clin. Investig."},{"key":"772_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177 (2017).","journal-title":"Cell"},{"key":"772_CR43","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.2147\/DDDT.S525651","volume":"19","author":"Z Cao","year":"2025","unstructured":"Cao, Z. et al. Glycolytic dysfunction in granulosa cells and its contribution to metabolic dysfunction in polycystic ovary syndrome. Drug Des. Devel. Ther. 19, 5255 (2025).","journal-title":"Drug Des. Devel. Ther."},{"key":"772_CR44","doi-asserted-by":"publisher","first-page":"4092470","DOI":"10.1155\/2020\/4092470","volume":"2020","author":"E Rudnicka","year":"2020","unstructured":"Rudnicka, E. et al. Inflammatory markers in women with polycystic ovary syndrome. Biomed. Res. Int. 2020, 4092470 (2020).","journal-title":"Biomed. Res. Int."},{"key":"772_CR45","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","volume":"51","author":"H Fang","year":"2019","unstructured":"Fang, H. et al. A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nat. Genet. 51, 1082\u20131091 (2019).","journal-title":"Nat. Genet."},{"key":"772_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"Roadmap Epigenomics Consortium","year":"2015","unstructured":"Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317 (2015).","journal-title":"Nature"},{"key":"772_CR47","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-019-0538-0","volume":"51","author":"CP Fulco","year":"2019","unstructured":"Fulco, C. P. et al. Activity-by-Contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664 (2019).","journal-title":"Nat. Genet."},{"key":"772_CR48","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.celrep.2016.10.061","volume":"17","author":"AD Schmitt","year":"2016","unstructured":"Schmitt, A. D. et al. A compendium of chromatin contact maps reveal spatially active regions in the human genome. Cell Rep. 17, 2042 (2016).","journal-title":"Cell Rep."},{"key":"772_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"772_CR50","doi-asserted-by":"publisher","first-page":"D983","DOI":"10.1093\/nar\/gkz888","volume":"48","author":"Z Zheng","year":"2020","unstructured":"Zheng, Z. et al. QTLbase: an integrative resource for quantitative trait loci across multiple human molecular phenotypes. Nucleic Acids Res. 48, D983\u2013D991 (2020).","journal-title":"Nucleic Acids Res."},{"key":"772_CR51","doi-asserted-by":"publisher","first-page":"D1032","DOI":"10.1093\/nar\/gkv1146","volume":"44","author":"S Joseph","year":"2016","unstructured":"Joseph, S., Barai, R. S., Bhujbalrao, R. & Idicula-Thomas, S. PCOSKB: a KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome. Nucleic Acids Res. 44, D1032\u2013D1035 (2016).","journal-title":"Nucleic Acids Res."},{"key":"772_CR52","doi-asserted-by":"publisher","first-page":"D1333","DOI":"10.1093\/nar\/gkad1005","volume":"52","author":"MA Gargano","year":"2024","unstructured":"Gargano, M. A. et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. 52, D1333\u2013D1346 (2024).","journal-title":"Nucleic Acids Res."},{"key":"772_CR53","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2020","unstructured":"Pi\u00f1ero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855 (2020).","journal-title":"Nucleic Acids Res."},{"key":"772_CR54","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1109\/TPAMI.2006.233","volume":"28","author":"L Grady","year":"2006","unstructured":"Grady, L. Random walks for image segmentation. IEEE Trans. Pattern Anal. Mach. Intell. 28, 1768\u20131783 (2006).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"772_CR55","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"772_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-014-0064-8","volume":"6","author":"H Fang","year":"2014","unstructured":"Fang, H. & Gough, J. The \u2018dnet\u2019 approach promotes emerging research on cancer patient survival. Genome Med. 6, 1\u201316 (2014).","journal-title":"Genome Med."},{"key":"772_CR57","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1126\/science.1065103","volume":"296","author":"S Maslov","year":"2002","unstructured":"Maslov, S. & Sneppen, K. Specificity and stability in topology of protein networks. Science 296, 910\u2013913 (2002).","journal-title":"Science"},{"key":"772_CR58","doi-asserted-by":"publisher","first-page":"016110","DOI":"10.1103\/PhysRevE.74.016110","volume":"74","author":"J Reichardt","year":"2006","unstructured":"Reichardt, J. & Bornholdt, S. Statistical mechanics of community detection. Phys. Rev. E 74, 016110 (2006).","journal-title":"Phys. Rev. E"},{"key":"772_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbrc.2013.11.103","volume":"443","author":"H Fang","year":"2014","unstructured":"Fang, H. & Gough, J. supraHex: An R\/Bioconductor package for tabular omics data analysis using a supra-hexagonal map. Biochem. Biophys. Res. Commun. 443, 285\u2013289 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"772_CR60","doi-asserted-by":"publisher","unstructured":"Bao, C. et al. A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation. https:\/\/doi.org\/10.1016\/j.crmeth.2024.100757(2024).","DOI":"10.1016\/j.crmeth.2024.100757"},{"key":"772_CR61","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1021\/jm100574m","volume":"53","author":"P Schmidtke","year":"2010","unstructured":"Schmidtke, P. & Barril, X. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J. Med. Chem. 53, 5858\u20135867 (2010).","journal-title":"J. Med. Chem."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00772-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:02:39Z","timestamp":1792368159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00772-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00772-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8610143\/v1","asserted-by":"object"}]},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"157"}}